Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-beta-OTX2-SNAIL via PTEN inhibition(1520 views) Ferrucci V, De Antonellis P, Pennino FP, Asadzadeh F, Virgilio A, Montanaro D, Galeone A, Boffa I, Pisano I, Scognamiglio I, Navas L, Diana D, Pedone E, Gargiulo S, Gramanzini M, Brunetti A, Danielson L, Carotenuto M, Liguori L, Verrico A, Quaglietta L, Errico ME, Del Monaco V, D'Argenio V, Tirone F, Mastronuzzi A, Donofrio V, Giangaspero F, Picard D, Remke M, Garzia L, Daniels C, Delattre O, Swartling FJ, Weiss WA, Salvatore F, Fattorusso R, Chesler L, Taylor MD, Cinalli G, Zollo M
Brain (ISSN: 1460-2156electronic, 0006-8950linking), 2018 May 1; 141(5): 1300-1319.
Keywords: Genetic Network, Medulloblastoma, Metastatic Cns Tumour, Molecular Genetics, Oncology, Nme1 Protein, Phosphatidylinositol 3, 5 Trisphosphate 3 Phosphatase, Prune1 Protein, Pyrimidine Derivative, Transcription Factor Otx2, Transcription Factor Snail, Transforming Growth Factor Beta, Unclassified Drug, Adolescent, Animal Experiment, Animal Tissue, Article, Cancer Cell, Cancer Growth, Cell Migration, Cell Proliferation, Child, Clinical Article, Complex Formation, Controlled Study, Female, Gene Expression, Gene Repression, Genetic Predisposition, Genetic Variability, Hek293t Cell Line, Human, Human Cell, Immunocompetent Cell, In Vivo Study, Infant, Luciferase Assay, Medulloblastoma Cell Line, Metastasis, Next Generation Sequencing, Nonhuman, Pediatrics, Primary Tumor, Priority Journal, Protein Binding, Protein Degradation, Protein Expression, Protein Interaction, Signal Transduction, Upregulation, Whole Exome Sequencing,
Affiliations: *** IBB - CNR ***
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universita degli Studi di Napoli Federico II, Naples, Italy., CEINGE Biotecnologie Avanzate, Naples, Italy., European School of Molecular Medicine (SEMM), Milan, Italy., Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Ontario, Canada., Dipartimento di Farmacia, Universita degli Studi di Napoli Federico II, Naples, Italy., Department of Veterinary Medicine and Animal Productions, Universita degli Studi di Napoli Federico II, Naples, Italy., Istituto di Biostrutture e Bioimmagini, Consiglio Nazionale della Ricerca, Naples, Italy., Dipartimento di Scienze Biomediche Avanzate, Universita degli Studi di Napoli Federico II, Naples, Italy., Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK., Paediatric Neurosurgery, Ospedale Santobono-Pausilipon, Naples, Italy., Pathology Unit, Ospedale Santobono-Pausilipon, Naples, Italy., Genetic Control of Development-URT, Institute of Cell Biology and Neurobiology, National Research Council, Fondazione Santa Lucia, Rome, Italy., Dipartimento di Onco-Ematologia, IRCCS Ospedale Pediatrico Bambino Gesu, Rome, Italy., Dipartimento di Scienze Radiologiche, Oncologiche e Anatomo Patologiche, Universita La Sapienza, Rome, Italy., IRCCS Neuromed, Pozzilli, Italy., German Cancer Consortium (DKTK), Department of Paediatric Oncology, Haematology, and Clinical Immunology, University Hospital Dusseldorf, Dusseldorf, Germany., Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto ON, Canada., PSL Research University, Inserm U830, Equipe Labellis?Ligue contre le Cancer, Institut Curie, Paris, France., Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Department of Neurology, University of California, San Francisco, San Francisco, CA, USA., Dipartimento di Scienze e Tecnologie Ambientali, Biologiche e Farmaceutiche, Caserta, Italy., DAI-Medicina Trasfusionale-Azienda Ospedaliera Universitaria Federico<
References: Not available.
Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-beta-OTX2-SNAIL via PTEN inhibition
Kállay C, Dávid A, Timári S, Nagy EM, Sanna D, Garribba E, Micera G, De Bona P, Pappalardo G, Rizzarelli E, Sóvágó I * Copper(II) complexes of rat amylin fragments(461 views) Dalton T (ISSN: 1477-9234, 1477-9226, 1477-9234electronic), 2011 Oct 14; 40(38): 9711-9721. Impact Factor:3.838 ViewExport to BibTeXExport to EndNote